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Abstract
Background
Persons with brain disorders experience significant psychosocial difficulties (PSD) in daily
life, e.g. problems with managing daily routine or emotional lability, and the level of the PSD
depends on social, physical and political environments, and psychologic-personal determi-
nants. Our objective is to determine a brief set of environmental and psychologic-personal
factors that are shared determinants of PSD among persons with different brain disorders.
Methods
Cross-sectional study, convenience sample of persons with either dementia, stroke, multi-
ple sclerosis, epilepsy, migraine, depression, schizophrenia, substance dependence or
Parkinson’s disease. Random forest regression and classical linear regression were used
in the analyses.
Results
722 subjects were interviewed in four European countries. The brief set of determinants
encompasses presence of comorbidities, health status appraisal, stressful life events,
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personality changes, adaptation, self-esteem, self-worth, built environment, weather, and
health problems in the family.
Conclusions
The identified brief set of common determinants of PSD can be used to support the imple-
mentation of cross-cutting interventions, social actions and policy tools to lower PSD experi-
enced by persons with brain disorders. This set complements a recently proposed reliable
and valid direct metric of PSD for brain disorders called PARADISE24.
Introduction
Brain disorders, such as dementia, stroke, Parkinson’s Disease (PD), depression and schizo-
phrenia, are mostly chronic neurological or psychiatric disorders of long duration which exert
a high degree of burden on daily life. Affected persons often react with distress when receiving
the diagnosis, have difficulties living with the illness, are often forced to dramatically change
their lifestyles and are at risk of being stigmatised [1]. Persons with brain disorders also experi-
ence significant psychosocial difficulties (PSD), ranging from problems with attention and
memory, emotional lability and listlessness to problems with managing their daily routines,
problems interacting with significant others and difficulties at work [2–6].
The severity of these PSDs depends on many factors in the close and extended environ-
ments, including social, physical and political environments. This understanding coincides
with the biopsychosocial model proposed in the International Classification of Functioning,
Disability and Health (ICF) (Fig 1), where functioning is defined as a continuum encompassing
body functions and structures and activities and participation and determined by interactions
between health conditions and contextual factors (environmental and personal factors) [7, 8].
According to the ICF model, PSDs have recently been specifically defined as impairments in
mental functions and body functions under nervous-system control, activity limitations and
participation restrictions resulting from interactions among the brain disorder, the environ-
ment and personal factors [9]. In this sense, living in the countryside, the availability of ade-
quate treatment, having a supportive work environment, high self-esteem or strong self-
confidence and successful coping strategies are examples of environmental and personal factors
which definitely determine the intensity of PSD accompanying a brain disorder.
In the ICF, environmental factors are defined in a very inclusive way, going far beyond the
built environment and encompassing factors such as health-service provision or quality of the
social environment. Formally, environmental factors are divided into five groups in the ICF:
[1] products and technology, [2] the natural environment, [3] support and relationships, [4]
attitudes of others, and [5] services, systems and policies [8]. Environmental factors include
medication and built environment, weather and climate, support provided by the family and
by health professionals, being treated with respect by family and friends and the provision of
health-care services. Personal factors have not yet been classified in the ICF, but were previ-
ously tentatively defined as “psychologic-personal factors” and subdivided into seven groups:
[1] socio-demographic personal characteristics, [2] position in the immediate social and physi-
cal context, [3] personal history and biography, [4] feelings, [5] thoughts and beliefs, [6]
motives and [7] patterns of experience and behaviour [10]. According to this categorization,
psychologic-personal factors include age, gender, being a caregiver, having experienced stress-
ful life events, knowledge and opinions about one’s own disease and interest in sports.
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According to the rationale of the ICF model, there is no reason to believe that determinants
of PSD are not shared across brain conditions. This hypothesis has recently been challenged,
and it has been clearly shown that several determinants of PSD, i.e. medication, assistance
from family and their attitudes and care from health professionals and their attitudes are com-
mon across brain disorders [9]. A recent review of qualitative studies has also identified eight
determinants shared among persons with very different brain disorders, such as substance
dependence, depression, epilepsy and multiple sclerosis (MS). In this work, stages in life and
associated roles, the presence of trusting or supportive informal and formal relationships, social
inclusion, availability of work opportunities and self-help groups, self-determination, contact
with motivated professionals and achieving a balance between protection and overprotection
were reported as shared determinants [11].
Knowledge of determinants of PSD across brain disorders is essential to provide health pro-
fessionals and policy makers with intervention targets and patients and their families with
insights about what can be done beyond pharmaceutical treatment to improve their lives.
Effective treatment strategies are available for some brain disorders, but usually focus on dis-
ease control and reduction of mostly acute symptoms. Due to the chronic, sometimes continu-
ous, sometimes degenerating character of brain disorders and the experienced PSDs, broader
strategies extending beyond merely targeting symptoms through medical interventions and
focusing on environmental aspects and personal factors are required. It is essential to achieve a
better understanding of the determinants of PSD to be able to design effective and sound inter-
ventions targeting environmental and personal factors and to eventually improve the lives of
Fig 1. The biopsychosocial model proposed in the International Classification of Functioning, Disability and Health (ICF).
doi:10.1371/journal.pone.0141322.g001
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persons with brain disorders. Since these persons experience common PSDs, a thorough
understanding of the determinants of PSD across brain disorders is indispensable for develop-
ing effective and efficient cross-cutting strategies.
Determinants of PSD experienced by persons with brain disorders in daily life have been
seldom considered in research. The available literature on the determinants of brain disorders
focuses mainly on factors related to the aetiology of these disorders, such as genetics, biomedi-
cal factors and environmental factors. Although efforts to identify risk factors to prevent the
emergence of brain disorders are undeniably essential, we must not forget the reasons why
brain disorders are among the most disabling of disorders. They are often chronic, some start
very early in life and have a meaningful cumulative impact on several aspects of daily life [12].
Furthermore, available information on the determinants of PSD is rare and traditionally
assessed from a disease-specific perspective. Although it is possible to search for shared deter-
minants in disease-specific publications, the comparability of the obtained information is
always limited because of the different methodologies or different assessment instruments
applied. It is essential to directly identify a set of determinants relevant across brain disorders
and suitable for guiding the development of cross-cutting interventions. Since the description
and assessment of PSDs is only meaningful if done in the context of their determinants, this set
would complement a recently proposed reliable and valid direct metric of PSD for brain disor-
ders called PARADISE24 [13].
The objective of this paper is to determine a brief set of environmental and psychologic-per-
sonal factors that are determinants of PSD experienced by persons with brain disorders. The
routine inclusion of this set in data collection could widen knowledge about the determinants
of burden across brain disorders, going beyond acknowledged determinants such as age or dis-
ease severity, and guide resource-allocation efforts towards developing and implementing
effective interventions to reduce the burden experienced by persons with brain disorders and
provide health professionals, policy makers, affected persons and their families with meaning-
ful intervention targets. To our knowledge, this is the first work specifically targeting determi-
nants of PSD across brain disorders.
Methods
Design and sample
This was a multi-centre, cross-sectional study carried out in the scope of the project PARA-
DISE (Psychosocial fActors Relevant to BrAin DISorders in Europe, www.paradiseproject.eu)
and involving four European study sites [9]. This project was funded under the FP7 by the
European Commission and had as a primary goal testing the hypothesis of commonalities
regarding PSD and determinants of PSD across brain disorders, i.e. that there are PSDs—
defined as impairments of mental functions and impairments of body functions under central
nervous system control, activity limitations and participation restrictions—and determinants
of PSD that are common in people with brain disorders despite variations in symptomatology,
aetiology, and the biochemical basis of their disorders. In the cross-sectional study a conve-
nience sample of 722 persons with dementia (N = 80), stroke (N = 80), multiple sclerosis (MS)
(N = 80), epilepsy (N = 80), migraine (N = 80), Parkinson’s Disease (PD) (N = 80), depression
(N = 81), schizophrenia (N = 81) or and substance dependency (N = 80) was included. Partici-
pants with stroke, MS, epilepsy, migraine and PD were recruited at the Neurological Institute
Carlo Besta IRCCS Foundation in Milan, Italy; participants with dementia and schizophrenia
at the Institute of Psychiatry and Neurology in Warsaw, Poland; participants with depression
at the teaching hospital La Princesa in Madrid, Spain; and participants with substance-depen-
dency at the Järvenpää Addiction Hospital in Haarajoki, Finland. Participants were interviewed
Determinants Difficulties Brain Disorders
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by trained clinical researchers using the PARADISE data collection protocol which included 64
PSDs and 59 PSDs determinants of PSDs considered to be common across brain disorders as
well as questions targeting demographic information, age, the impact of comorbidities, and dis-
ease severity. Individuals participating in the study had to meet the following general inclusion
criteria: age 18 years; main diagnosis (according to ICD-10) of one of the disorders listed
above; and the individual had been informed of the purpose and rationale of the study and had
signed the “patient consent form”. Further information about the study and the PARADISE
protocol is reported in detail elsewhere [13]. The study was conducted in conformity with the
ethical principles of the European Commission Research Ethics Committee. The study and the
informed consent used were approved by the Ethics Committee of the Ludwig-Maximilian
University of Munich, as well as by the Ethics Committees of the Neurological Institute Carlo
Besta IRCCS Foundation in Milan, Italy, the Institute of Psychiatry and Neurology in Warsaw,
Poland, the teaching hospital La Princesa of the University of Madrid in Madrid, Spain and the
Järvenpää Addiction Hospital in Haarajoki, Finland. Individuals participating in the study
were informed of the purpose and rationale of the study by a recruiting nurse and signed a
patient consent form approved by the Ethics Committees.
Data analysis
Descriptive statistics were used to characterize the sample. Environmental and psychologic-
personal factors included in the PARADISE protocol were split into three groups: “psychologic-
personal factors I”, including sociodemographic characteristics, position in the immediate
social and physical context and personal history and biographic information, “psychologic-per-
sonal factors II”, including information on thoughts and beliefs and patterns of experience and
behaviour, and “environmental factors”. Detailed information on all determinants is provided
elsewhere [9].
In the “psychologic-personal factors I” group, items addressing factors such as disease dura-
tion, health-care use, health appraisal and the living and working situation were included.
Besides these variables, four Patient Reported Outcome (PRO) tools were included. The impact
of comorbidities was assessed using the Self-Reported Comorbidities Questionnaire (SCQ) [14],
from which a summary score is derived by adding up to three points obtained from each of the
reported health conditions: one point for its presence, one if treatment is received and one if it
causes decrements in functioning. Higher scores indicate a higher comorbidity impact. Quality
of life was assessed using eight questions from theWHOQuality of Life (WHOQOL-8) ques-
tionnaire [15] and social support was evaluated using the Oslo Social Support Scale (OSS) [16].
Stressful life events were assessed with the Social Readjustment Rating Scale (SRRS), and an
index reflecting the number of events experienced in the past year was created [17].
In the “psychologic-personal factors II” group, items addressing factors such as personality
changes, self-worth, and personal beliefs and adaptation, were included. Three patient-reported
outcome (PRO) instruments were also included: the Big Five Inventory [18], the Brief Resilient
Coping Scale [18] and two items from the General Self-Efficacy Scale (GSES) [19], which were
recently identified as sufficient to measure the concept in a psychometric study applying Rasch
analysis [20].
“Environmental factors” included items addressing factors such as facilitating and hindering
aspects of medication, the built environment, public transportation, weather or climate, atti-
tudes and support given by others. Two questions were stated for all items: “To what extent
does/do . . . have a positive influence on your difficulties?” and “To what extent does/do . . . have
a negative influence on your difficulties?”. The Jefferson Scale of Patient Perceptions of Physi-
cian Empathy [21] was also used to assess physicians’ empathy.
Determinants Difficulties Brain Disorders
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The PARADISE24 metric, our dependent variable, provides a single score to estimate the
impact of brain disorders on people’s lives, and was developed using Rasch analyses [9]. This
metric ranges from zero (no PSDs) to 100 (extreme PSDs). We estimated Spearman correlation
coefficients between each of the 59 determinants and the PARADISE24 score to come up with
a pre-selection of the most relevant determinants of PSD across brain disorders. Determinants
were selected for further analyses if the association was>0.20. This rather conservative cut-off
was selected having in mind that correlations of 0.2 may already be regarded as noteworthy
and demonstrate some relationship. In setting this cut-off, we intended to reduce the number
of predictors but at the same time keep all determinants which had at least some association
with the outcome and might become significant predictors.
The most relevant determinants of PSD were then identified by means of random forest
regression using the PARADISE24 score as the dependent variable. This regression method
can handle a large number of predictors, even in the presence of multicollinearity, and provide
unbiased variable importance estimates. The random forest provides a ranking of importance
of the independent variables included in the model with regard to their explanatory value for a
response variable [10].
The determinants of PSD included in the analyses were also split into three groups: “psycho-
logic-personal factors I”, “psychologic-personal factors II” and “environmental factors”. A ran-
dom forest regression was carried out separately for each group. Using the resulting ranking of
importance, the increase in explained variance was calculated for each random forest regres-
sion with a classical linear regression analysis [22]. Starting with the most important variable in
each group-specific regression, variables of the three random forests were included stepwise in
a final single model, and the changes in the coefficient of determination (R2) were observed.
Cook’s D was used to detect eventual outliers. A brief set of the most important determinants
was selected based on the change in R2 curves and the p-value of the regression analyses. The
cforest function from the R-package “party” estimated the random forests [23–25]. This analy-
sis included only individuals with less than 40% missing values, which were imputed with the
R-package missForest [26]. Regression analyses were controlled for age, gender and level of
education.
Data analyses were performed in SPSS, SAS and R.
Results
Sample
Altogether 722 subjects were interviewed. Due to cognitive limitations, interviews were carried
out with proxies for eight persons with depression, two with stroke and 21 with dementia. The
mean interview duration ranged from 51.05 minutes in migraine to 133.97 minutes in demen-
tia. The characteristics of the included population are reported in Table 1.
Overall, 44 determinants of PSD had an association with the PARADISE24 score higher
than>0.20 (data not shown) and were included in further analyses (Table 2).
Results of the random forest and linear regressions are reported in Table 3. For each deter-
minant group, the first two columns report the importance estimate and the ranking of impor-
tance estimated with random forest regression, respectively. Columns R2 adjusted and R2
report the increase in explained variance calculated with classical linear regression analysis by
adding the determinants stepwise in rank order to the model. Using the obtained forest-based
ranking of importance for the three groups and the increase in the explained variance (R2
adjusted), 24 determinants were selected for the final random forest and linear models (final
regression analysis column). These results identified the 11 most important determinants:
three factors from the psychologic-personal factors I group (presence of comorbidities,
Determinants Difficulties Brain Disorders
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personal appraisal of health status and experience of stressful life events), five variables from
the psychologic-personal factors II group (changes in personality, adaptation on the part of the
persons and of others, self-esteem and self-confidence) and three environmental factors (built
environment, weather or climate, and health problems of members of the family). Fig 2 sum-
marizes the health conditions, the PSD included in the PARADISE24 metric, and the identified
determinants in the present study.
Discussion
In the present work, we determined a brief set of environmental and psychologic-personal fac-
tors that are determinants of PSDs experienced by persons with brain disorders. To our knowl-
edge, this is the first work specifically targeting determinants of PSD looking for determinants
valid across brain disorders. The identified determinants, namely comorbidities, personal
appraisal of health status, stressful life events, personality, adaptation, self-esteem, self-worth,
built environment, weather and health problems of family members provide useful informa-
tion to introduce the implementation of cross-cutting interventions, social actions and policy
tools to lower PSD experienced in daily life by persons with brain disorders. This set can also
be used to complement a recently proposed reliable and valid direct metric of PSD for brain
disorders called PARADISE24 [13].
The advantage of the present work is its use of a comprehensive definition of both PSD
experienced by persons with brain disorders and its determinants. Relying on the biopsychoso-
cial framework proposed by the WHO, we understand PSD (also referred to as “burden”), as
impairments in mental functions and body functions under nervous-system control, activity
limitations and participation restrictions resulting from the interaction between the brain dis-
order, environmental and personal factors. The diversity of the determinants identified as the
most relevant in our work, namely the negative impact of the weather, the built environment
and the presence of health problems among family members, might sound peculiar at first
glance. They coincide with the broad definition of environmental factors proposed in the ICF,
which includes products and technology (like medication or built environment), the natural
environment, compromising weather conditions, social and professional support and attitudes
and services, systems and policies. This broad conceptualization implies a large range of inter-
vention targets to impact PSD, moving the focus from exclusively curative or symptom-ori-
ented strategies to strategies that target changing or adapting the environment, which is a
common strategy in degenerative diseases, but still a rare approach in brain disorders.
The added value of identifying the negative impact of weather or climate, which encom-
passes temperature, humidity and precipitation, among other factors, and the negative impact
of the built environment, which includes design, construction and building of entrances, exits,
Table 1. Characteristics of the included population.
Depression Epilepsy Migraine Multiple
Sclerosis
Parkinson Stroke Schizophrenia Dementia Substance
dependence
Sample size N 81 80 80 80 80 80 81 80 80
Age in years Mean
(SD)
54.81
(14.73)
41.23
(11.99)
44.54
(12.12)
41.03 (8.74) 61.24
(10.45)
59.84
(14.36)
38.38 (14.03) 81.03
(5.49)
39.56 (13.15)
Gender Female
(%)
82.7 50.0 86.3 65.0 40.0 43.8 53.1 78.8 37.5
Disease
duration in
years
Mean
(SD)
12.63
(11.57)
18.67
(12.32)
21.13
(14.60)
7.66 (6.94) 6.26 (4.40) 4.00
(6.48)
13.03 (11.83) 3.69 (2.70) 12.16 (8.67)
doi:10.1371/journal.pone.0141322.t001
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Table 2. Questions or questionnaires used to assess the determinants of psychosocial difficulties
(PSD) selected for further analyses and split into three groups: “psychologic-personal factors I”,
“psychologic-personal factors II” and “environmental factors.”
Determinant (Questions or questionnaires)
Control variables
Age
Level of education
Gender
Psychologic-personal factors I
Disease duration (Since when have you had the <health condition>?)
Number of visits to a medical doctor (How many visits did you make to a medical doctor (GP and specialist)
during the past 12 months due to your < health condition >?)
Comorbidities (Self-Reported Comorbidities Questionnaire)
Quality of life (WHOQOL)
In general, how would you rate your health today?
Living situation (What is your general living situation?)
Working situation (What is your current working situation?)
Care-giving role (Over the last 12 months, have any members of your household, adults or children,
needed your care or support for any reason? This could include ﬁnancial, physical, emotional, health or
personal care or support)
Stressful life events (Stressful events Index)
Psychologic-personal factors II
Personality—Neuroticism (Big Five Inventory—Neuroticism)
Personality—Do you think that you have become a different kind of person because of
your < health condition >?
Resilience (Brief Resilience Scale)
Self-worth (To what extent do you see yourself as equally worthwhile and deserving as other
people?)
Sense of belonging (To what extent do you feel like you belong when attending activities in the
community?)
Personal beliefs (To what extent do your personal beliefs give you the strength to face difﬁculties?)
Self-efﬁcacy (To what extent are you conﬁdent you can ﬁnd the means and ways to get what you want if
someone opposes you?)
Self-efﬁcacy (To what extent are you conﬁdent that you could deal efﬁciently with unexpected events?)
Self-esteem (To what extent do you think that many people view < health condition > or problems
related to your < health condition > as something that lessens your value as a person?)
Adaptation (Generally, have you learned to live with (do you accept) the problems and difﬁculties
your <health condition > has led to in your life?)
Adaptation (Generally, do you think that the people around you have come to terms with your
problems and difﬁculties?)
Environmental factors
To what extent do side effects of medications make your difﬁculties worse?
The medication you receive (+)§(–)#
The way the environment around you is (+) (-)
The way public transportation works (+) (-)
Weather or climate (+) (-)
The awareness of HC that people around you have in general (+) (-)
The help and assistance you receive from your family (+) (-)
The help and assistance you receive from your friends (+) (-)
The help and assistance of your peers or colleagues (+) (-)
The care from health professionals (+) (-)
(Continued)
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and facilities, as strong predictors of the experienced burden directs the attention of policy
makers to the need for environmental interventions and adaptations for individuals with brain
disorders. The need to adapt the built environment is very intuitive in disorders leading to
wheelchair use, as is the case in MS or PD [28]. Our results point out, however, that the built
environment also exerts a significant negative impact on other brain disorders, such as demen-
tia, depression and substance dependence [9]. Our hypothesis is that the interplay between
PSD experienced by persons with brain disorders (e.g., cognitive problems, low energy levels
and pain) and the built environment is as important as its interplay with limitations in mobil-
ity. The impact of weather or climate on PSD has been examined and corroborated in relation
to behavioural and psychological problems in dementia [29], and psychotic exacerbation in
schizophrenia [30]. It is also thought to trigger migraines [31] and influence admission rates
for affective disorders [32] and disease progression in MS [33]. In our previous study, rates of
patients considering the weather or climate to have an impact on PSD ranged from 61% in sub-
stance dependence, 69% in dementia, 78% in schizophrenia and up to 90% in migraine [9].
The present study stresses the negative impact of these determinants on PSD, since the ques-
tions targeting a potential positive impact of weather and built environment did not remain in
the final regression model. The specific features of the built environmental and weather nega-
tively impacting PSD cannot, however, be fully explained by our data, and corresponding qual-
itative studies among persons with brain disorders are lacking. A better understanding of the
needs of persons with brain disorders regarding built environmental and weather is required
for adequate policies to be developed and implemented.
The third determinant identified refers to the presence of health problems of family mem-
bers. In our study, this environmental factor was pointed out as a determinant by 50% or more
persons with migraine, dementia, depression, schizophrenia and substance dependence. A
hypothesis that might explain this result is that social support on the part of the family, i.e.
emotional and financial support, advocacy and housing, which has been recognized as an
important protective factor in depression [34] and schizophrenia [35] is threatened if family
members are themselves ill. In the light of our results, the assessment of the presence of health
problems among family members is highly recommended to clinicians and health professionals
involved in the treatment of persons with brain disorders and interested in reducing their expe-
rienced burden. It should be taken in account in clinical work and the community should pro-
vide enough support for these families.
The conceptualization of determinants used in our work goes beyond environmental factors
and includes personal and psychological factors as important determinants of PSD. The four
psychological variables identified as determinants encompass changes in personality, adapta-
tion on the part of affected persons and persons close to them, self-esteem and self-worth. The
key role played by psychological features in the experienced burden of persons with brain dis-
orders, for example in self-esteem, has been extensively reported in the literature [36, 37]. The
added value of our work here is to show that these psychological features are relevant across
brain disorders. Especially adaptation, i.e. whether the person has learned to live with the
Table 2. (Continued)
Determinant (Questions or questionnaires)
The health problems of other family members (+) (-)
§ (+): positive inﬂuence of determinant on PSD.
# (-): negative inﬂuence of determinant on PSD.
doi:10.1371/journal.pone.0141322.t002
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problems and difficulties associated with his or her brain disorder and whether the person
thinks that the people around him/her have come to terms with their problems and difficulties,
were very important determinants of the experienced burden across disorders. Our findings
have significant implications for clinicians and health professionals and stress the importance
of providing psychological and psychosocial treatment and encouraging participation in self-
help groups and patients’ organizations to emphasise adaptation in the absence of curative
strategies and improve self-esteem and self-worth among persons with brain disorders in gen-
eral. Our work stresses the importance of existing disease-specific strategies and encourages
the development of cross-cutting strategies for brain disorders in general.
The three psychologic-personal factors identified in our work as determinants of PSD across
brain disorders are not surprising from a disease-specific perspective, but highly important
from the perspective of so-called “horizontal epidemiology”. It is well known that comorbidi-
ties are highly prevalent in persons with brain disorders, which has been extensively discussed
in the WHO’s initiative “No Health without Mental Health”. This is especially important
because the provision and the quality of care that people with mental disorders receive is worse
than in the general population [1]. Stressful life situations, an established risk factor and trigger
for the development of several conditions, especially mood disorders [38], as well as the
Fig 2. Summary of health conditions and the identified determinants (environmental and psychologic-personal factors). * The psychosocial
difficulties included in the PARADISE24 metric and used to identify the determinants are: energy and drive, motivation, appetite, sleep, attention, memory,
psychomotor difficulties, agitation & aggression, depressive mood, worry and anxiety, stress, making decisions, pain, sexual activities (body-function
domains); communication, walking, washing oneself, independence in everyday activities, looking after one’s health, informal relationships with friends,
family and intimate relationships, education/work and employment, managing money, joining in community activities (activities-and-participation domains).
doi:10.1371/journal.pone.0141322.g002
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subjective appraisal of one’s own health status, which is an acknowledged powerful predictor of
mortality [39], were also identified as valuable predictors of PSD in brain disorders. We there-
fore emphasise the importance of a careful assessment of comorbidities and stressful life situa-
tions and the need for sound disease-management strategies in all brain disorders. Moreover,
our work discloses that the subjective appraisal of health status, a frequently-used predictor of
mortality, can also be used by researchers to predict the experienced burden in brain disorders.
Our study has three strengths worth mentioning. First, we relied on the recently challenged
and confirmed hypothesis of horizontal epidemiology, namely that PSDs experienced in daily
life by persons with brain disorders are similar across conditions because they are understood
as the outcome of the interaction between the disorder and environmental and personal fac-
tors. The fact that PSDs—in terms of burden—are shared supported the idea of looking for a
set of common determinants of PSD across brain disorders. Preliminary research going beyond
a disease-specific approach and looking at determinants across disorders supports our findings,
so that we definitely recommend further studies using the same perspective. A direct and
hugely important consequence of more knowledge about common determinants of PSD is the
development of cross-cutting interventions and universal policy strategies. Second, we are tar-
geting not determinants of the development of disorders, which has already been extensively
carried out, but determinants of PSD experienced in daily life by persons living with brain dis-
orders. Knowledge of determinants, risk factors and the aetiology of brain disorders has been
continuously expanded, for instance by carrying out life-course, risk-modelling exercises [40]
or focusing on the interactions among determinants during life stages [41, 42]. Although such
efforts are undeniably valuable to develop primary prevention strategies, the high prevalence of
brain disorders has a huge impact on daily life [1] and urgently requires research on determi-
nants which can be targeted to alleviate the experienced burden of the population currently
affected by brain disorders. Third, this set of 11 determinants is suitable to complement a
recently proposed reliable and valid direct metric of PSD in brain disorders called PARA-
DISE24. To become a comprehensive tool corresponding with horizontal epidemiology,
authors stress the need to add key determinants to this metric, like environmental and psycho-
logic-personal factors, which interact with brain-disorder and are determinants of PSDs. Our
set provides these key determinants.
Our findings have to be viewed in the light of their limitations. First, we used a convenience
sample of persons with brain disorders, so the generalizability of our results is unclear. Studies
with larger and representative samples, especially taking into account the inclusion of persons
with different disease severity, are required to confirm our results. Second, we collected infor-
mation during an interview, and this might have influenced the answers to sensitive topics,
such as the positive and negative influence of the access to illegal drugs or alcohol on the expe-
rienced PSD. We might have missed important determinants sensitive to social-desirability
bias. Finally, we collected information on the direction (positive or negative) and the extent of
this influence using the response options none, mild, moderate or strong on the determinants
on the PSD. It is not possible to further disclose how determinants impact PSDs or which
determinants impact which specific PSD. In the scope of PARADISE we have published a qual-
itative study exploring the experiences of people with seven brain disorders regarding PSDs
and determinants of PSD, which can be seen as complementary to the present work [11]. Since
the knowledge coming from qualitative studies is essential to develop interventions, we
strongly encourage researchers to embark in future similar qualitative studies including further
brain disorders.
In summary, we identified a brief set of environmental and personal determinants of PSD
experienced by persons with brain disorders. We recommend that this set be used together
with the PARADISE24 metric to provide a comprehensive picture of the experienced burden
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and its determinants. The routine inclusion of our set in data collection is a first step towards
expanding the knowledge about determinants of PSD across brain disorders and might be used
to guide health professionals, policy makers, affected persons and their families in the develop-
ment and implementation of effective interventions or actions to reduce the burden experi-
enced by persons with brain disorders. Since our data does not provide a specific
understanding of how determinants like built environment and weather influence PSD, we
encourage researchers to carry out qualitative studies to further explore these interactions.
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